Skip to search boxSkip to navigationSkip to main content

Endobronchial metastases in breast carcinoma

  • A. N. Krutchik
    ,
  • C. K. Tashima
    ,
  • A. U. Buzdar
    ,
  • G. R. Blumenschein
  • University of Texas MD Anderson Cancer Center
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

In a consecutive series of 1,628 patients with breast carcinoma, six cases of endobronchial metastases were diagnosed for an incidence of 0.4 percent. The median latent interval from the diagnosis of the primary carcinoma until the time of diagnosis of endobronchial metastases was 21 months. Endobronchial metastases can be the initial manifestation of recurrent cancer and can present with no abnormalities shown on x-ray films of the chest. Because of similar symptomatology, the diagnosis of endobronchial metastases may be confused with a central bronchogenic carcinoma but the histological appearance could differentiate the two entities. Local treatment with radiation therapy is usually inadequate and patients should also be treated with some form of systemic treatment such as chemotherapy. The median survival after the diagnosis of endobronchial metastases was 13 months.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 177-180 (4 pages)

Journal (Volume, Issue Number)

Western Journal of Medicine (Volume 129, Issue 3)

Publication milestones

  • Published - 12/01/1978

Publication status

Published - 12/01/1978

ISSN

0093-0415

Publication IDs

  • Scopus: 0018237895
  • PubMed: 706354

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1

PlumX

Citation count
11